Turning Breakthrough Science
Into Enduring Companies.
We back breakthrough science to build category-defining healthcare companies.
From first cheque to international scale, we stay close. We invest early, focus on outcomes, and measure success by real-world health impact — not just returns.
Financial. Relational.
Our Views on Venture:
We look for bold inventions with multi billion dollar markets gravity — built to pull in the best minds in science and scale.
What
We invest in complex problems solved through scientific engineering — unlocking new markets at the convergence of biology and technology.
Who
Founders with deep domain fluency — in TechBio, Advanced Therapeutics, MedTech, AI, HealthTech, Digital Health and Programmable Health.
Where
Across the UK, Europe, and MEA — ecosystems we know, and systems we want to change.
When
Early — from Pre-Seed to Series A. We underwrite meaningful technical and commercial risk.
How
Excellence. Innovation. Teamwork. Passion. Integrity.
More Than Capital
Capital opens the door. What happens next defines the company.
Panacea Capital is built for the early stage — when nothing is obvious, and everything matters.
We offer more than capital. We bring a system. A strategy. And a set of frameworks forged at the frontier.
Here’s where we go deep:
Preclinical Clarity &
Regulatory Precision.
We work upstream of validation, where strategy begins with the bench.
We help teams navigate the grey zones — from exploratory data to defined pathways.
We support experimental design, regulatory positioning, and preclinical strategy that’s purpose-built for translation — not just publication.
Product-Clinic Fit
(Not Just Product-Market Fit).
We measure fit not just by users, but by use.
In healthcare, traction isn’t always revenue.
We focus on clinical pull, validation logic, and adoption design — helping founders define products that move from theory to system.
AI-Native Strategies
with Real-World Endpoints.
Interpretability matters.
We don’t fund black boxes.
We back companies where AI is the core engine — not a slide.
From data infrastructure to model design, we help teams define value around measurable, clinically-relevant endpoints.
Business Models for Global Health Markets.
We understand how care gets delivered, regulated, and paid for — in complex systems across borders.
We work with founders to model incentives, economics, and rollout — from day one.
You can’t scale what doesn’t translate.
Structured Paths to Institutional Capital.
Our platform doesn’t just open doors — it aligns the next ones.
From cap table design to investor readiness, we help founders raise capital that compounds — not just capital that clears.
We prepare founders for institutional rounds long before they meet institutional investors.
Scientific Translation & Strategic Framing.
We don’t simplify science. We make it legible.
We help founders sharpen how their science is communicated — to investors, partners, and regulators — without diluting its complexity.
We co-develop narrative, not just decks.
Embedded Infrastructure via the Panacea Platform.
The playbook comes with the platform.
Our companies plug into a broader system: Panacea Stars (venture building), Panacea Guild (talent + partner network), and our advisory architecture.
This isn’t just a fund. It’s a full-stack ecosystem.
Founder Psychology &
Strategic Decision Support.
We’re built for the messiest, most meaningful moments.
We’ve backed 400+ companies at the most high-pressure, identity-shaping moments.
We know how decision-making warps at the edge — and we help founders navigate risk, dilution, pacing, and team dynamics when it matters most.
Tiered Capital Through a Unified System.
You grow. The strategy grows with you.
Our tiered investment vehicles allow us to match capital to maturity — without resetting the founder’s journey.
We back companies with consistency, from origin to scale.
We’re truly invested.
And we stay aligned through the moments that matter most.